INKT

MiNK Therapeutics, Inc. - Common Stock (INKT)

About MiNK Therapeutics, Inc. - Common Stock (INKT)

MiNK Therapeutics, Inc. is a clinical stage biopharmaceutical company, which engages in the discovery, development, and commercialization of allogeneic invariant natural killer T cell therapies to treat cancer and other immune mediated diseases. The company was founded by Garo H. Armen in 2017 and is headquartered in New York, NY.

Details

Daily high
$12.08
Daily low
$11.70
Price at open
--
52 Week High
$16.98
52 Week Low
$8.48
Market cap
61.5M
Dividend yield
-
Volume
5
Avg. volume
13,781
P/E ratio
-5.03

MiNK Therapeutics, Inc. - Common Stock News

Details

Daily high
$12.08
Daily low
$11.70
Price at open
--
52 Week High
$16.98
52 Week Low
$8.48
Market cap
61.5M
Dividend yield
-
Volume
5
Avg. volume
13,781
P/E ratio
-5.03